期刊文献+

左小腿肿物伴肺脑转移 被引量:2

A Patient with Neoplasm in the Left Leg with Lung and Brain Metastases
下载PDF
导出
摘要 腺泡状软组织肉瘤(ASPS)是一种罕见的软组织肿瘤,其组织起源尚未定论,往往伴有不平衡染色体易位t(X;17)(p11.2;q25)并导致产生融合基因ASPL-TFE3。发生部位主要位于四肢尤其是下肢的深部软组织。组织学可见瘤细胞呈特征性的腺泡或巢团样排列,胞质内可见嗜伊红颗粒及结晶体。好发于年轻女性,虽然临床生长缓慢,但易血行转移,预后差,主要转移部位为肺、骨、肝、脑。广泛切除是治疗的关键,辅助放、化疗效果差。天津医科大学附属肿瘤医院报道1例37岁女性患者,左小腿腺泡状软组织肉瘤伴肺、脑转移,病程18年,先后给予手术治疗、放射治疗及介入治疗,由于肺转移灶再次进展,给予免疫治疗、分子靶向治疗及中医药治疗。本文旨在探讨现代治疗方法能否延长患者生存时间。 Alveolar soft part sareoma (ASPS) is a tare soft tissue tumor of uncertain histogenesis with a non-reiprocal transloeation der (17) t (X;17) (p1 1.2; q25) leading to the fusion of the ASPL gene to the gene encoding transcription faetor TEF3. ASPS is mainly found in the extremities, especially the deep soft parts of lower limbs. Histologically, the tumor shows typical alveolar and nest arrangcmcnt with eosinophilic granules or crystals in the cytoplasm of tumor eells. ASPS often occurs in young women. Ahhough it displays a slow elinieal course, it often melastasizes to the lung, bone, liver and brain, worsening the prognosis. Complete resection is critieat tor treatment of localized alveolar soft part sarcolna. Adjuvant chemotherapy and radiotherapy have demonstrated few benefits. Here. we present a case of primary ASPS of the left leg with lung and brain metastases in a 37-year-old woman. Site underwent surgery, radiotherapy and interventional therapy. Because of the progression of metastases in her lungs site was also given immunotherapy, molecular target therapy and traditional Chinese medicine. We investigate whether the modern treatment can prolong the survival of ASPS patients.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第6期353-356,共4页 Chinese Journal of Clinical Oncology
关键词 腺泡状软组织肉瘤 病理特征 治疗 Alveolar soft part sareoma (ASPS) Pathological features Treatment
  • 相关文献

参考文献13

  • 1庞丽娟,李锋,陆天才.腺泡状软组织肉瘤组织起源和分子遗传学研究进展[J].国外医学(肿瘤学分册),2003,30(6):472-475. 被引量:4
  • 2蔡建强,邵永孚,石远凯,王绿化.腺泡状软组织肉瘤22例临床治疗分析[J].中华普通外科杂志,1999,14(2):130-132. 被引量:6
  • 3邓元,张学斌,王鸿雁,王敏,张群岭.腺泡状软组织肉瘤28例临床病理分析[J].诊断病理学杂志,2004,11(6):383-385. 被引量:10
  • 4庞丽娟,李锋,胡文浩,常彬.腺泡状软组织肉瘤多处转移病理特点及文献复习[J].农垦医学,2004,26(1):42-43. 被引量:1
  • 5Heimann P, Devalck C, Debusscher C, et al. Alveolar soft-part sarcoma: further evidence by FISH for the involvement of chromosome band 17q25 [J]. Genes Chromosomes Cancer, 1998, 23(2): 194-197.
  • 6van Ruth S, van Goevorden F, Peterse JL, et al. Alveolar soft part sarcoma. A report of 15 cases [J]. Eur J Cancer, 2002, 38 (10): 1324-1328.
  • 7Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century [J]. Cancer, 1989, 63(1): 1-13.
  • 8Wagner A. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs [J]. J Natl Compr Canc Netw, 2007, 5(4):401-410.
  • 9Nakamura T, Tanaka K, Matsunobu T, et al. The mechanism of cross-resistance to proteasome inhibitor bortezomib and overcoming resistance in Ewing's family tumor cells [J]. Int J Oncol, 2007, 31(4): 803-811.
  • 10McMeekin DS, Sill MW, Darcy KM, et al. A phase Ⅱ trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biornarkers of angiogenesis: a gynecologic oncology group study[J]. Gynecol Oncol, 2007, 106(3):596-603.

二级参考文献45

  • 1张学斌,陈高平.1021例软组织肉瘤的病理活检统计分析[J].西安医科大学学报,1993,14(4):383-386. 被引量:14
  • 2戚威,张秀兰,刘惠萍.腺泡状软组织肉瘤41例临床分析[J].中国矫形外科杂志,1996,3(3):176-177. 被引量:2
  • 3[5]Roai J, Dias P, Parham DM. et al. MyoD1 protein expression in Alveolar soft part sarcoma as comfirmatory evidence of its skeletal muscle nature.Am J Surg Pathol, 1991,15:974 ~ 981
  • 4[6]Heimann P, Devalck C, Debusscher C,et al. Alveolar soft - part sarcoma:further evidence by FISH ofr the involvement of chromosome band 17q25Genes Chromosomes Cancer, 1998,23 (2): 194 ~ 197
  • 5[7]Ladanyi M,Lui MY, Antonescu CR.el al. The der(17)t(x; 17)(pll;q25)of hunan alveolar soft part sarcona fuses the TFE3 trascription factor gene to ASPL, a novel gene at 17q25.
  • 6[8]Sandberg A, Bridge J. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors:alveolar soft part sarcoma. Cancer Genet Cytogenet. 2002. 136 (1 : 1 ~ 98Sandberg A, Bridge J. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma. Cancer GeneelCytogenet, 2002.136(1): 1 ~ 9
  • 7[1]Christopherson WM, Foote FW. Stewart FW. Alveolar soft part sarcoma:structurally characteristic tumors of uncertain histogenesis. Cancer, 1952,5:100
  • 8[2]Enzinger FM. Soft tissue tumors, In: Alveolar soft part sarcoma, 4th ed.USA:mosby Press,2002:1509 ~ 1521
  • 9[3]Cullinane C, Thomer PS, Greenberg ML, et al. Molecular genetic.cytogenetic and inmunohistochemical characterization of alveolar soft part sarcoma: Implication for cell of origin, Cancer, 1992,70: 2444 ~ 2450
  • 10[4]Hirose T, Kudo E, Hasegawa T, et al, Cytoskeletal properties of alveolar soft part sarcoma, Humao Pathol, 1990,21: 204 ~ 211

共引文献17

同被引文献19

  • 1Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma: a clinico-pathologic study of half a century. Cancer, 1989, 63 : 1-13.
  • 2Enzinger FM. Soft tissue tumors//Enzinger FM, Weiss SW. Alveolar soft part sarcoma. 4th ed. St Louis, Missouri : Mosby, 2002 : 1509- 1521.
  • 3Anderson ME, Homicek FJ, Gebhardt MC, et al. Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res, 2005, 438 : 144-148.
  • 4Azizi AA, Haberler C, Czech T, et al. Vascular-endothelial-growth- factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma. Lancet Oneol, 2006, 7:521-523.
  • 5Benetos IS, Mavrogenis AF, Soultanis KCh, et al. Mveolar soft part sarcoma of the forearm: a case report. J Surg Orthop Adv, 2006, 15:209-213.
  • 6Heimann P, Devalck C, Debusscher C, et al. Alveolar soft-part sarcoma: further evidence by FISH for the involvement of chromosome band 17q25. Genes Chromosomes Cancer, 1998,23 : 194-197.
  • 7Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X; 17) (p11; q25 ) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene, 2001, 20:48-57.
  • 8Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev, 2004, 30:83-101.
  • 9Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg, 1999, 229:602-610.
  • 10Putnam JB Jr, Roth JA. Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North Am, 1995, 9:869-887.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部